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Summary
Severe combined immunodeficiency disease (SCID) con-
sists of a group of heterogeneous genetic disorders. The
most severe phenotype, TB SCID, is inherited as an
autosomal recessive trait and is characterized by a pro-
found deficiency of both T cell and B cell immunity.
There is a uniquely high frequency of TB SCID among
Athabascan-speaking Native Americans (A-SCID). To
localize the A-SCID gene, we conducted a genomewide
search, using linkage analysis of ∼300 microsatellite
markers in 14 affected Athabascan-speaking Native
American families. We obtained conclusive evidence for
linkage of the A-SCID locus to markers on chromosome
10p. The maximum pairwise LOD scores 4.53 and 4.60
were obtained from two adjacent markers, D10S191 and
D10S1653, respectively, at a recombination fraction of
. Recombination events placed the gene in anv  .00
interval of ∼6.5 cM flanked by D10S1664 andD10S674.
Multipoint analysis positioned the gene for the A-SCID
phenotype between D10S191 and D10S1653, with a
peak LOD score of 5.10 at D10S191. Strong linkage
disequilibrium was found in five linked markers span-
ning ∼6.5 cM in the candidate region, suggesting a foun-
der effect with an ancestral mutation that occurred
sometime before 1300 A.D.
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Introduction
Severe combined immunodeficiency disease (SCID) rep-
resents a group of genetically and phenotypically het-
erogeneous disorders, all of which result in T cell with
or without B cell immunodeficiency (Fischer 1992; Ro-
sen et al. 1995). SCIDwith the TB phenotype accounts
for ∼45% of cases, two-thirds of which are inherited as
X-linked, common g-chain-receptor deficiency (Noguchi
et al. 1993; Mathews et al. 1995). The remaining one-
third of TB SCID cases have autosomal recessive in-
heritance and include JAK3 protein-kinase deficiency
(Russell et al. 1995) and ZAP70 deficiency (Elder et al.
1994). The most severe form of SCID is characterized
by the TB phenotype and represents ∼30% of cases.
Genes encoding proteins that affect the V(D)J (i.e., var-
iable, diversity, joining) recombination reaction have
been suggested as potential targets for TB SCID (Tac-
cioli and Alt 1995), and some TB SCID patients have
been found to carry mutations in the recombinase-ac-
tivating genes (RAGs) (Schwarz et al. 1996), whereas
some have been found to show irregular V(D)J recom-
bination events (Schwarz et al. 1991; Abe et al. 1992).
However, the underlying pathogenesis for the majority
of TB SCID patients is still unknown. The remaining
25% of SCID cases include patients with Omenn syn-
drome, adenosine deaminase deficiency (Hirschhorn
1993), and reticular dysgenesis.
An increased incidence of TB SCID is found among
Athabascan-speaking (A-SCID), Navajo, and Apache
Native Americans (Murphy et al. 1980; Hu et al. 1988;
Jones et al. 1991). We also have identified the same
phenotype in two related families (three affected pa-
tients) among the Dine´ Indians, a small tribe of Atha-
bascan speakers living in the Northwest Territories. The
incidence of TB SCID among Navajo Indians is
∼1/2,000 live births, with no known etiology (Hu et al.
1988; Jones et al. 1991). Autosomal recessive transmis-
sion of the disorder is supported by the incidence of
multiple affected siblings with unaffected parents and by
other results from pedigree and population-genetics
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Figure 1 Pedigrees of 14 families with A-SCID. An asterisk (*) below a circle or a square indicates an individual who participated in the
study. Blackened circles and squares denote affected individuals; a diagonal line indicates that the individual is deceased. Family 21 was of
Apache origin, and family 17 was of Dine´ origin, whereas all others were Navajo. The genotypes for 10 linked microsatellite markers on
chromosome 10p are presented in the following order (from top to bottom): D10S585, D10S1430, D10S223, D10S1725, D10S1664,D10S191,
D10S1653, D10S674, D10S1477, and D10S1423. The genotypes of D10S585 for the healthy sibling in family 21 were not determined, which
is indicated by hyphens (-).
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Table 1
Candidate Genes Excluded for Genetic Linkage with A-SCID
Gene(s) Function Location
IL-7 Stimulates pre–B cells and pre–T cells in bone
marrow
8q12-13
IL-7 receptor Expressed in pre-T and pre-B cells 5p13
RAG1, RAG2 Activates V(D)J recombination 11p12-13
XRCC-7 Encodes p350, which regulates V(D)J
recombination
8q11
XRCC-5 Encodes Ku80, which is involved in V(D)J
recombination
2q33-35
XRCC-4 Encodes a protein involved in V(D)J recombination 5q13-14
XRCC-6 Encodes Ku70, which is involved in V(D)J
recombination
22q13, 10q22-24a
a XRCC-6 was also found to be weakly hybridized to 10q22-24 (Cai et al. 1994).
studies, which estimate the gene frequency to be 2.1%
in the Navajo (Jones et al. 1991). All patients have sim-
ilar laboratory findings of severe T and B lymphopenia
(lymphocyte counts !500, with !5% T and B cells) and
very low (!5% of normal) to absent lymphocyte pro-
liferation in response to mitogens and alloantigens. No
other hematopoietic cell lineage is affected in this dis-
ease. Clinically, affected children present with oral/gen-
ital ulcers (Murphy et al. 1980; Rotbart et al. 1986; Hu
et al. 1988) and life-threatening infections, within the
first 3 mo of life. Without a bone-marrow transplant, a
large majority die by 6 mo of age (Dror et al. 1993).
To localize the A-SCID gene, we conducted a ge-
nomewide search, using ∼300 polymorphic microsatel-
lite markers in 14 Athabascan-speaking Native Ameri-
can families with at least one affected individual. Here
we report the results of our linkage and genetic analyses,




The identification, clinical assessment, and sample col-
lection of A-SCID families were achieved in collabora-
tion with pediatricians at the University of Colorado
Health Science Center (for family 19), the University of
Alberta (for family 17), the White River Apache Health
Service (for family 21), and the Tuba City Indian Health
Services (for all other families and the normal controls).
For all cases, the clinical and laboratory diagnoses were
confirmed by M.J.C. Blood samples and skin biopsies
for fibroblast cultures (for A-SCID patients only) were
collected from affected and unaffected individuals from
the participating families, after informed consent was
obtained. The study was approved by the Committee on
Human Research at the University of California San
Francisco (UCSF) and the Navajo Nation Health Board.
Fourteen families were used for the linkage analysis (fig.
1), including 12 Navajo families, 1 Apache family, and
1 Dine´ family. These 14 kindreds comprised 18 affected
children, 28 parents, and 35 healthy full siblings. The
parents of kindred 1 were very distant cousins (five gen-
erations removed), and the parents of kindred 16 were
from the same clan, although there was no known con-
sanguineous relationship; all other families were not ex-
plicitly consanguineous. No cross-consanguinity with
other tribes could be traced among the families. Finally,
we performed cytogenetic analyses of fibroblast-cell cul-
tures from three Navajo children with A-SCID; all had
normal karyotypes (data not shown).
Genetic Markers
A total of ∼300 microsatellite markers were typed.
The majority of them were chosen from published ge-
netic maps (Gyapay et al. 1994; Murray et al. 1994; Dib
et al. 1996), whereas others were selected frompublished
polymorphic markers in the Genome Database (http://
www.gdb.org). The markers covered all the autosomal
chromosomes, with an average separation of 10–20 cM.
The areas containing genes with known functions related
to the features of TB SCID were covered with more
densely spaced (1–10 cM) markers. The general map
positions of markers were based on published infor-
mation (Murray et al. 1994; Dib et al. 1996). For mark-
ers in the vicinity of the candidate region, the map po-
sitions were determined by use of the Ge´ne´thon linkage
map (Dib et al. 1996), with additional information taken
from the Massachusetts Institute of Technology (MIT)/
Whitehead Institute sequence-tagged site (STS) map
(Hudson et al. 1995). Approximately one-third of the
markers were synthesized by Dr. Bruce Shiramizu’s lab-
oratory at UCSF, and two-thirds were purchased from
Research Genetics.
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Table 2
Pairwise LOD Scores between A-SCID and Candidate Regions
GENE(S) AND
MARKER
LOD SCORE AT v 
vmax.00 .05 .10 .15 .20 .25 .30
IL-7 and XRCC-7:
D8S531  2.31 1.27 .75 .45 .26 .14 .5
D8S519  3.34 1.98 1.27 .82 .52 .31 .5
D8S538  .45 .20 .09 .03 .00 .00 .5
D8S285  3.06 1.80 1.12 .69 .41 .23 .5
D8S166  2.18 1.21 .70 .40 .22 .11 .5
CRH  1.55 .60 .18 .02 .10 .11 .4
D8S84  .98 .33 .07 .05 .08 .08 .3
D8S88  1.30 .53 .23 .10 .04 .02 .5
RAG1 and RAG2:
D11S2001  6.81 3.83 2.34 1.44 .87 .49 .5
D11S2014  4.55 2.54 1.51 .89 .50 .27 .5
D11S907  2.39 1.43 .91 .57 .35 .20 .5
D11S935  2.15 1.30 .84 .54 .34 .20 .5
D11S1360  1.60 .86 .48 .26 .13 .06 .5
D11S905  3.09 1.75 1.06 .64 .38 .21 .5
D11S1313  3.99 2.47 1.62 1.07 .68 .41 .5
D11S1314  .43 .12 .01 .07 .08 .07 .25
D11S873  3.14 1.61 .87 .46 .23 .10 .5
XRCC-5:
CTLA4  3.42 2.06 1.34 .89 .58 .35 .5
D2S325  2.22 1.22 .73 .44 .26 .14 .5
D2S137  .83 .12 .11 .17 .16 .12 .2
D2S173  1.57 .76 .42 .25 .15 .09 .5
XRCC-4:
D5S647  2.78 1.64 1.09 .74 .50 .32 .5
D5S351  4.95 3.05 2.03 1.37 .90 .55 .5
D5S357  3.73 2.14 1.38 .93 .61 .38 .5
D5S626  1.81 1.04 .66 .42 .26 .16 .5
XRCC-6:
D22S301  3.03 1.77 1.13 .73 .46 .27 .5
D22S343  1.01 .05 .07 .11 .11 .08 .25
D22S281  2.68 1.35 .75 .42 .22 .11 .5
IL2RB  .67 .41 .28 .19 .13 .08 .5
Genotyping
DNA was prepared by use of standard methods (Ford
et al. 1989), from peripheral blood samples, fibroblast
cultures, or Epstein-Barr virus–transformed lymphocytes
(the transformation was performed for family 19 by
A.H.). The microsatellite markers were typed by PCR,
followed by separation on 6% polyacrylamide sequenc-
ing gels. The method used is similar to that described
by Weber and May (1989). The PCR reactions were
performed with 30–60 ng of genomic DNA as templates;
10–30 pmol of each primer; 1 mCi of a-[33P]dATP; 200
mM dGTP, dTTP, and dCTP; 2.5 mM dATP; and 0.5 U
of Taq polymerase (Boehringer Mannheim), in a final
volume of 10–15 ml. The PCR profile was as follows:
95C for 5 min, then 35 cycles of 95C for 30 s, 55–60C
for 1–2 min, and 72C for 30–60 s, followed by exten-
sion at 72C for 7 min.
Linkage Analysis
Two-point and multipoint linkage analyses were per-
formed by use of the MLINK and LINKMAP programs,
respectively, of the LINKAGE package, version 5.1 (Ter-
williger and Ott 1994). The genetic model used in the
analysis was that for a fully autosomal recessive trait.
Calculations assumed a disease-gene frequency of .021
and no sex difference, as reported elsewhere (Jones et
al. 1991). Allele frequencies for all markers were kept
equal, while every genotype at a locus in a pedigree was
required to be known, for analysis. The map distances
were calculated by use of the Haldane mapping function.
The marker order and genetic distances used for the
multipoint analysis were determined by use of the Ge´-
ne´thon linkage map (Dib et al. 1996), and the following
mapping information for D10S674 was taken from the
MIT/Whitehead Institute map (Hudson et al. 1995):




The most frequent allele of each marker detected in
disease chromosomes was assumed to be the disease-
associated allele, and all others were classified as non-
associated alleles. Control allele distributions were de-
termined from 30 unrelated individuals from unaffected
families of 100% Navajo origin. The significance of al-
lelic association for the 32 Navajo A-SCID chromo-
somes at each locus within the candidate region was
determined by the statistics x2 and d (Lehesjoki et al.
1993; Devlin and Risch 1995): d  P  (P excess affected
, in which Paffected is the proportion ofP )/(1 P )normal normal
disease-associated alleles in disease chromosomes and
Pnormal is the proportion in control chromosomes. Hap-
lotypes were inferred so that recombinants were
minimized.
Results
Exclusion of Genetic Linkage with Candidate Regions
The areas containing genes with known functions re-
lated to the features of TB SCID were typed with
densely spaced markers and analyzed. The candidate
genes consisted of those for interleukin-7 (IL-7) and the
IL-7 receptor and those involved in V(D)J recombina-
tion. Their locations are summarized in table 1 (Oettin-
ger et al. 1990, 1992; Jeggo et al. 1992; Lynch et al.
1992; Mombaerts et al. 1992; Shinkai et al. 1992;
Muegge et al. 1993; Cai et al. 1994; Peschon et al. 1994;
Taccioli et al. 1994; Blunt et al. 1995; Kirchgessner et
al. 1995; Li et al. 1995; Otevrel and Stamato 1995). The
pairwise LOD scores are presented in table 2. No linkage
was found between markers in these eight locations and
the A-SCID gene.
Genetic Linkage between A-SCID and Chromosome
10p Markers
Before linkage with the 10p markers was found, there
were several regions (1q21-31, 4q28-33, 5q33-35, 7p21-
15, 9p24-21, 10q11-21, and 11q23-24) with markers
showing a degree of linkage with A-SCID. However,
additional studies, using more markers closely spaced
around the suspected region, excluded linkage (data not
shown). After ∼300 markers were typed, linkage at 10p
was detected. The first evidence was found with
D10S1430. Additional markers typed in the region prox-
imal to D10S1430 confirmed the linkage, with no evi-
dence of heterogeneity (table 3). The highest LOD
scores, 4.53 and 4.60, were observed for markers
D10S191 and D10S1653, respectively, at a recombina-
tion fraction (v) of .00. The haplotypes are shown in
figure 1. Recombination events in families 5, 14, 16, and
17 positioned the A-SCID gene between D10S1664 and
D10S674 (a 6.5-cM interval). The two loci with the
highest LOD scores, D10S191 and D10S1653, are lo-
cated within this interval. Multipoint analysis placed the
A-SCID locus between markers D10S191 and
D10S1653, with a maximum multipoint LOD score
(Zmax) of 5.10 at D10S191 (fig. 2).
Linkage-Disequilibrium Analysis
Allele frequencies for Navajo disease-bearing (n 
) and control ( ) chromosomes, with results of32 n  60
the x2 test and the disequilibrium parameter d for the
associated allele, are given in table 4. Significant linkage
disequilibrium was found in five adjacent marker loci in
the candidate region ( ). The evidence of strongestP ! .01
disequilibrium was found at D10S1653, where there is
a striking excess of allele 2 or allele 4 on A-SCID chro-
mosomes versus that on control chromosomes. There is
also a significant excess of alleles 4, 8, 4, and 5 at mark-
ers D10S1664, D10S191, D10S674, and D10S1477, re-
spectively. Marker D10S1653 is associated with two dif-
ferent alleles, allele 2 in 50% of A-SCID chromosomes
and allele 4 in 41% of A-SCID chromosomes. The likely
explanation is a mutation at the D10S1653 locus, most
likely an early mutational event, since the rare ancestral
alleles were significantly retained at both loci flanking
D10S1653. It is also possible that the mutation from
allele 4 to allele 2 (and from allele 2 to allele 4) occurs
at a frequency high enough that the two alleles are ef-
fectively the same.
The linkage disequilibrium with these five loci, cov-
ering a relatively large region, suggests a founder effect.
The two Apache A-SCID–bearing chromosomes carry
the same disease-associated alleles 4, 8, 4/2, 4, and 5 at
loci D10S1664, D10S191, D10S1653, D10S674, and
D10S1477, respectively, and the four Dine´ A-SCID chro-
mosomes carry the common allele 8 at D10S191 (data
not shown).
Discussion
In a genomewide scan for linkage to A-SCID, we an-
alyzed ∼300 microsatellite markers in 14 families from
three different Athabascan-speaking Native American
tribes. We studied 80 individuals, 18 of whom were af-
fected with A-SCID of an identical phenotype. Fifteen
of the affected individuals were of Navajo descent, one
was an Apache Indian, and two were Dine´ Indians from
the Northwest Territories. We excluded most of the au-
tosomal genome, including regions encoding products
involved in V(D)J recombination or IL-7 and its receptor.
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Table 3
Pairwise LOD Scores between A-SCID and 10p Markers
MARKER AND
TRIBE
LOD SCORE AT v 
Zmax vmax
DISTANCE
(cM).00 .02 .04 .06 .08 .10
D10S585:  3.50 3.51 3.39 3.22 3.02 3.53 .03 0a
Navajo  3.39 3.42 3.31 3.15 2.96
Apache .12 .11 .09 .08 .07 .06
Dine´b ) ) ) ) ) )
D10S223:  2.32 2.45 2.44 2.37 2.27 2.45 .05 3.1a
Navajo  3.20 3.07 2.91 2.74 2.57
Apache .12 .11 .09 .08 .07 .06
Dine´  .99 .71 .55 .44 .36
D10S1725:  1.51 1.64 1.65 1.60 1.53 1.65 .05 5.5a
Navajo  2.34 2.26 2.12 1.97 1.83
Apache .12 .11 .09 .08 .07 .06
Dine´  .99 .71 .55 .44 .36
D10S1664:  2.93 2.97 2.88 2.74 2.57 2.98 .03 7.4a
Navajo  4.20 3.92 3.66 3.39 3.11
Apache .18 .16 .14 .13 .12 .10
Dine´  1.11 .81 .65 .53 .44
D10S191:c 4.53 4.23 3.94 3.65 3.37 3.09 4.53 0 7.4a
(5.20) (4.91) (4.62) (4.32) (4.03) (3.75) (5.20) (0)
Navajo 4.41 3.96 3.83 3.55 3.28 3.01
Apacheb ) ) ) ) ) )
Dine´ .12 .12 .11 .10 .09 .08
D10S1653: 4.60 4.32 4.04 3.77 3.50 3.24 4.60 0 9.9a
Navajo 4.48 4.21 3.95 3.69 3.43 3.18
Apache .12 .11 .09 .08 .07 .06
Dine´b ) ) ) ) ) )
D10S674:  1.31 1.71 1.86 1.89 1.86 1.89 .08 12d
Navajo  3.41 3.25 3.07 2.88 2.69
Apache  .12 .11 .09 .08 .07
Dine´  2.21 1.63 1.29 1.06 .89
D10S1477:  2.04 2.35 2.41 2.37 2.29 2.40 .06 12a
Navajo  4.14 3.89 3.62 3.36 3.12
Apache .12 .11 .09 .08 .07 .06
Dine´  2.21 1.63 1.29 1.06 .89
D10S1423:  .26 .79 1.05 1.18 1.24 1.25 .12 16d
Navajo  2.63 2.56 2.47 2.36 2.23
Apache .18 .16 .14 .13 .12 .10
Dine´  2.21 1.63 1.29 1.06 .89
a Distance from D10S585, as given in the Ge´ne´thon linkage map (Dib et al. 1996).
b Uninformative for the marker.
c The data omit the information from family 19, in which two affected and one unaffected offspring
have nonpaternal alleles that appear to be from a mutation at the marker locus. The data determined
after replacement with paternal alleles are given in parentheses.
d As given in the MIT/Whitehead Institute STS map (Hudson et al. 1995).
A total of eight regions showed preliminary evidence for
linkage, and seven of them also were excluded after stud-
ies with a denser array of markers. Only markers on
chromosome 10p were confirmed for linkage with
A-SCID, and the conclusive pairwise LOD scores 4.53
and 4.60 were achieved with marker loci D10S191 and
D10S1653, respectively, at .v  0
Analysis of recombinants placed the gene in a 6.5-cM
interval that contains the two loci with the highest LOD
scores. There is no evidence of clinical or laboratory
heterogeneity for A-SCID. Genetic homogeneity is sug-
gested by combination of the phenotypic identity and
the results of linkage and haplotype analyses. However,
the genetic evidence for the Dine´ group is not conclusive,
given that the disease-associated allele is present only at
one locus and that a limited number of disease chro-
mosomes were available for analysis. Studies of more
A-SCID families from the Apache and Dine´ are needed
to confirm this observation.
Our results from allele-association studies of linked
markers further confirmed the location of the A-SCID
gene and indicated that the genemust be genetically close
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Figure 2 Multipoint linkage analysis between A-SCID locus and
selected markers on chromosome 10p, for 14 families. D10S1664 was
arbitrarily assigned position 0, and the order and genetic distances of
the marker loci were determined by use of the Ge´ne´thon genetic map
(Dib et al. 1996).
Table 4




NO. OF ASSOCIATED ALLELES/n (%)
x2 P daA-SCID Chromosomes Control Chromosomes
D10S1725 2 19/32 (59) 27/58 (46) 1.36 .244 .24
D10S1664 4 23/32 (72) 11/60 (18) 25.68 !.001 .66
D10S191 8 28/32 (88) 14/58 (24) 33.27 !.001 .84
D10S1653 2/4 29/32 (91) 21/60 (35) 26.03 !.001 .86
D10S674 4 22/32 (69) 8/58 (14) 28.03 !.001 .64
D10S1477 5 20/32 (63) 20/60 (33) 7.22 .007 .45
D10S1423 4 10/38 (26) 8/60 (13) 2.43 .119 .15
a .d  P  (P  P )/(1 P )excess affected normal normal
to D10S1653. This allelic association suggests that most
patients carry the same mutation of identical origin. The
results are very interesting when we combine informa-
tion from the history and migration pattern of these
Indian tribes. The Navajo and Apache originated from
the same Na-Dene subdivision of the Athabascan-speak-
ing linguistic group that migrated to the U.S. Southwest
around 1300 A.D. and that separated into two groups
around 1500 A.D. (Krauss 1979; Murphy et al. 1980;
Kehoe 1981a, 1981b). In our study, the two Apache A-
SCID–bearing chromosomes (from an affected family
that, on the basis of family history, was determined to
be unrelated to the Navajo) carry the same disease-as-
sociated alleles on all five loci in the candidate region.
The best explanation for the identity of their phenotype
and genotype seems to be that they are carrying the same
founder mutation, which occurred before their separa-
tion around 1500 A.D. In addition, before the migration
of the Na-Dene group, around 1300 A.D., the Athabas-
can-speaking people were hunting-gathering groups liv-
ing in the Northwest Territories.
The Dine´ tribe is a small Athabascan-speaking Indian
tribe that lives in the Northwest Territories.We identified
two related families with the A-SCID phenotype and
were able to include one family (with two affected chil-
dren) in our study. These two families are not related to
the Navajo or Apache, and the four A-SCID–bearing
chromosomes carry the same disease-associated allele 8
at D10S191. Therefore, it is possible that they also carry
the same mutation as that of the Navajo and Apache
A-SCID patients.
Thus, when the phenotypic identity of A-SCID is com-
bined with the results from our linkage, linkage-dise-
quilibrium, and haplotype analyses, as well as with the
information from population history, the best explana-
tion for our results is that the Navajo, Apache, and Dine´
descended from the same ancestors and carry the same
ancestral mutation for A-SCID, which occurred in one
of their common ancestors sometime before 1300 A.D.
It will be difficult to assign a more precise age to the
mutation until additional studies of the Dine´ and other
Athabascan-speaking populations in the Northwest Ter-
ritories and Alaska are completed. The founder effect
for the incidence of A-SCID has been suspected before
(Murphy et al. 1980). Our results provide the evidence
to support the founder-effect theory.
The 6.5-cM candidate interval is a large region for
positional cloning. There have been five genes and ∼50
transcripts mapped to the region within which this in-
terval is found. None of these genes have known func-
tions obviously related to features of A-SCID.Additional
fine mapping, with more markers within the candidate
interval and with more disequilibrium studies, is nec-
essary. This work is in progress in our laboratory, and
it should refine the candidate region to a size more suit-
able for positional cloning.
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